To examine the impact of FGF9 on NASH‐driven hepatic tumorigenesis, we fed FGF9Alb mice a HFHC diet for 10 months (Figure 7H). The gene discussed is FGF9; the disease is metabolic dysfunction-associated steatohepatitis.